Matrix Metalloproteinase 9

"Matrix Metalloproteinase 9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.

Descriptor ID	D020780
MeSH Number(s)	D08.811.277.656.300.480.205.360 D08.811.277.656.300.480.252.445 D08.811.277.656.300.480.525.700.350 D08.811.277.656.675.374.205.360 D08.811.277.656.675.374.252.445 D08.811.277.656.675.374.525.700.350 D12.644.276.848.350 D12.776.467.836.350
Concept/Terms	Matrix Metalloproteinase 9 Matrix Metalloproteinase 9 Metalloproteinase 9, Matrix 92-kDa Type IV Collagenase 92 kDa Type IV Collagenase Matrix Metalloproteinase-9 MMP9 Metalloproteinase Metalloproteinase, MMP9 MMP-9 Metalloproteinase MMP 9 Metalloproteinase Metalloproteinase, MMP-9 92-kDa Gelatinase 92 kDa Gelatinase Gelatinase B

Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 9".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Hydrolases [D08.811.277]
Peptide Hydrolases [D08.811.277.656]
Endopeptidases [D08.811.277.656.300]
Metalloendopeptidases [D08.811.277.656.300.480]
Collagenases [D08.811.277.656.300.480.205]
Matrix Metalloproteinase 9 [D08.811.277.656.300.480.205.360]
Gelatinases [D08.811.277.656.300.480.252]
Matrix Metalloproteinase 9 [D08.811.277.656.300.480.252.445]
Matrix Metalloproteinases [D08.811.277.656.300.480.525]
Matrix Metalloproteinases, Secreted [D08.811.277.656.300.480.525.700]
Matrix Metalloproteinase 9 [D08.811.277.656.300.480.525.700.350]
Metalloproteases [D08.811.277.656.675]
Metalloendopeptidases [D08.811.277.656.675.374]
Collagenases [D08.811.277.656.675.374.205]
Matrix Metalloproteinase 9 [D08.811.277.656.675.374.205.360]
Gelatinases [D08.811.277.656.675.374.252]
Matrix Metalloproteinase 9 [D08.811.277.656.675.374.252.445]
Matrix Metalloproteinases [D08.811.277.656.675.374.525]
Matrix Metalloproteinases, Secreted [D08.811.277.656.675.374.525.700]
Matrix Metalloproteinase 9 [D08.811.277.656.675.374.525.700.350]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Intercellular Signaling Peptides and Proteins [D12.644.276]
Matrix Metalloproteinases, Secreted [D12.644.276.848]
Matrix Metalloproteinase 9 [D12.644.276.848.350]
Proteins [D12.776]
Intercellular Signaling Peptides and Proteins [D12.776.467]
Matrix Metalloproteinases, Secreted [D12.776.467.836]
Matrix Metalloproteinase 9 [D12.776.467.836.350]

Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 9".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Matrix Metalloproteinase 9" by people in this website by year, and whether "Matrix Metalloproteinase 9" was a major or minor topic of these publications.

Bar chart showing 73 publications over 24 distinct years, with a maximum of 9 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	1	1
1996	0	1	1
1998	0	1	1
2002	0	1	1
2003	3	1	4
2004	1	1	2
2005	1	1	2
2006	1	4	5
2007	1	2	3
2008	0	3	3
2009	2	1	3
2010	2	2	4
2011	3	6	9
2012	1	6	7
2013	0	3	3
2015	3	4	7
2016	0	4	4
2017	1	2	3
2018	1	1	2
2019	1	1	2
2020	2	1	3
2021	1	0	1
2023	0	1	1

Below are the most recent publications written about "Matrix Metalloproteinase 9" by people in Profiles.

Hamze K, Abdallah RH, Younis NK, Fardoun M, Darwiche N, Kobeissy F, Iratni R, Bouhadir K, Eid AH. 2-Nucleobase-substituted 4,6-Diaminotriazine Analogs: Synthesis and Anti-cancer Activity in 5-Fluorouracil-sensitive and Resistant Colorectal Cancer Cells. Curr Med Chem. 2023; 30(26):3032-3049.

View in: PubMed
Okada T, Suzuki H, Travis ZD, Altay O, Tang J, Zhang JH. SPARC Aggravates Blood-Brain Barrier Disruption via Integrin aV?3/MAPKs/MMP-9 Signaling Pathway after Subarachnoid Hemorrhage. Oxid Med Cell Longev. 2021; 2021:9739977.

View in: PubMed
Hilliard A, Mendonca P, Russell TD, Soliman KFA. The Protective Effects of Flavonoids in Cataract Formation through the Activation of Nrf2 and the Inhibition of MMP-9. Nutrients. 2020 Nov 27; 12(12).

View in: PubMed
Eastman AJ, Vrana EN, Grimaldo MT, Jones AD, Rogers LM, Alcendor DJ, Aronoff DM. Cytotrophoblasts suppress macrophage-mediated inflammation through a contact-dependent mechanism. Am J Reprod Immunol. 2021 03; 85(3):e13352.

View in: PubMed
Hernandes-Alejandro M, Monta?o S, Harrington CR, Wischik CM, Salas-Casas A, Cortes-Reynosa P, P?rez Salazar E, Cazares-Apatiga J, Apatiga-Perez R, Ontiveros Torres M?, Perry G, Pacheco-Herrero M, Luna-Mu?oz J. Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease. J Alzheimers Dis. 2020; 76(2):553-569.

View in: PubMed
Esemu LF, Yuosembom EK, Fang R, Rasay S, Fodjo BAY, Nguasong JT, Kidima W, Ekali GL, Chen JJ, Ndhlovu L, Bigoga JD, Taylor DW, Leke RGF, Babakhanyan A. Impact of HIV-1 infection on the IGF-1 axis and angiogenic factors in pregnant Cameroonian women receiving antiretroviral therapy. PLoS One. 2019; 14(5):e0215825.

View in: PubMed
Wang X, Rojas-Quintero J, Wilder J, Tesfaigzi Y, Zhang D, Owen CA. Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces. J Immunol. 2019 06 01; 202(11):3267-3281.

View in: PubMed
McBride DW, Gren ECK, Kelln W, Hayes WK, Zhang JH. Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats. J Neurosci Res. 2020 01; 98(1):191-200.

View in: PubMed
Dutta P, Sarkissyan M, Paico K, Wu Y, Vadgama JV. MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis. Breast Cancer Res Treat. 2018 Aug; 170(3):477-486.

View in: PubMed
Liu HF, Liu H, Lv LL, Ma KL, Wen Y, Chen L, Liu BC. CCN3 suppresses TGF-?1-induced extracellular matrix accumulation in human mesangial cells in vitro. Acta Pharmacol Sin. 2018 Feb; 39(2):222-229.

View in: PubMed

People

Explore

Similar Concepts

Top Journals